BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Corrective action for Liaison® Control Biotrin Parvovirus B19 IgM, Diasorin

2014.01.20

Product group In-vitro diagnostics - microbiological products
Reference 07115/13

Corrective action from Diasorin for Liaison® Control Biotrin Parvovirus B19 IgM due to an incorrect Negative Control range. Customers were again informed about the problem.

Corrective action for Liaison® Control Biotrin Parvovirus B19 IgM, Diasorin , Download_VeroeffentlichtAm_EN PDF, 109KB, File does not meet accessibility standards